Literature DB >> 24567514

Cancer evolution: the final frontier of precision medicine?

Charles Swanton1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24567514      PMCID: PMC4433531          DOI: 10.1093/annonc/mdu005

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  16 in total

1.  Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.

Authors:  Ryohei Katayama; Alice T Shaw; Tahsin M Khan; Mari Mino-Kenudson; Benjamin J Solomon; Balazs Halmos; Nicholas A Jessop; John C Wain; Alan Tien Yeo; Cyril Benes; Lisa Drew; Jamal Carlos Saeh; Katherine Crosby; Lecia V Sequist; A John Iafrate; Jeffrey A Engelman
Journal:  Sci Transl Med       Date:  2012-01-25       Impact factor: 17.956

2.  EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

Authors:  Young Lim Choi; Manabu Soda; Yoshihiro Yamashita; Toshihide Ueno; Junpei Takashima; Takahiro Nakajima; Yasushi Yatabe; Kengo Takeuchi; Toru Hamada; Hidenori Haruta; Yuichi Ishikawa; Hideki Kimura; Tetsuya Mitsudomi; Yoshiro Tanio; Hiroyuki Mano
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245

3.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer.

Authors:  Peter J Campbell; Shinichi Yachida; Laura J Mudie; Philip J Stephens; Erin D Pleasance; Lucy A Stebbings; Laura A Morsberger; Calli Latimer; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena A Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Constance A Griffin; John Burton; Harold Swerdlow; Michael A Quail; Michael R Stratton; Christine Iacobuzio-Donahue; P Andrew Futreal
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

4.  Tumour evolution inferred by single-cell sequencing.

Authors:  Nicholas Navin; Jude Kendall; Jennifer Troge; Peter Andrews; Linda Rodgers; Jeanne McIndoo; Kerry Cook; Asya Stepansky; Dan Levy; Diane Esposito; Lakshmi Muthuswamy; Alex Krasnitz; W Richard McCombie; James Hicks; Michael Wigler
Journal:  Nature       Date:  2011-03-13       Impact factor: 49.962

5.  Inferring tumor progression from genomic heterogeneity.

Authors:  Nicholas Navin; Alexander Krasnitz; Linda Rodgers; Kerry Cook; Jennifer Meth; Jude Kendall; Michael Riggs; Yvonne Eberling; Jennifer Troge; Vladimir Grubor; Dan Levy; Pär Lundin; Susanne Månér; Anders Zetterberg; James Hicks; Michael Wigler
Journal:  Genome Res       Date:  2009-11-10       Impact factor: 9.043

6.  Tracking the clonal origin of lethal prostate cancer.

Authors:  Michael C Haffner; Timothy Mosbruger; David M Esopi; Helen Fedor; Christopher M Heaphy; David A Walker; Nkosi Adejola; Meltem Gürel; Jessica Hicks; Alan K Meeker; Marc K Halushka; Jonathan W Simons; William B Isaacs; Angelo M De Marzo; William G Nelson; Srinivasan Yegnasubramanian
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

7.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

8.  Genetic variegation of clonal architecture and propagating cells in leukaemia.

Authors:  Kristina Anderson; Christoph Lutz; Frederik W van Delft; Caroline M Bateman; Yanping Guo; Susan M Colman; Helena Kempski; Anthony V Moorman; Ian Titley; John Swansbury; Lyndal Kearney; Tariq Enver; Mel Greaves
Journal:  Nature       Date:  2010-12-15       Impact factor: 49.962

9.  Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.

Authors:  Marco Gerlinger; Stuart Horswell; James Larkin; Andrew J Rowan; Max P Salm; Ignacio Varela; Rosalie Fisher; Nicholas McGranahan; Nicholas Matthews; Claudio R Santos; Pierre Martinez; Benjamin Phillimore; Sharmin Begum; Adam Rabinowitz; Bradley Spencer-Dene; Sakshi Gulati; Paul A Bates; Gordon Stamp; Lisa Pickering; Martin Gore; David L Nicol; Steven Hazell; P Andrew Futreal; Aengus Stewart; Charles Swanton
Journal:  Nat Genet       Date:  2014-02-02       Impact factor: 38.330

10.  The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.

Authors:  Luis A Diaz; Richard T Williams; Jian Wu; Isaac Kinde; J Randolph Hecht; Jordan Berlin; Benjamin Allen; Ivana Bozic; Johannes G Reiter; Martin A Nowak; Kenneth W Kinzler; Kelly S Oliner; Bert Vogelstein
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

View more
  15 in total

Review 1.  Brain metastasis: new opportunities to tackle therapeutic resistance.

Authors:  Joan Seoane; Leticia De Mattos-Arruda
Journal:  Mol Oncol       Date:  2014-06-02       Impact factor: 6.603

2.  Effective quality management practices in routine clinical next-generation sequencing.

Authors:  Francine B de Abreu; Jason D Peterson; Christopher I Amos; Wendy A Wells; Gregory J Tsongalis
Journal:  Clin Chem Lab Med       Date:  2016-05       Impact factor: 3.694

3.  phyC: Clustering cancer evolutionary trees.

Authors:  Yusuke Matsui; Atsushi Niida; Ryutaro Uchi; Koshi Mimori; Satoru Miyano; Teppei Shimamura
Journal:  PLoS Comput Biol       Date:  2017-05-01       Impact factor: 4.475

4.  Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.

Authors:  Gretchen K Hubbard; Laura N Mutton; May Khalili; Ryan P McMullin; Jessica L Hicks; Daniella Bianchi-Frias; Lucas A Horn; Ibrahim Kulac; Michael S Moubarek; Peter S Nelson; Srinivasan Yegnasubramanian; Angelo M De Marzo; Charles J Bieberich
Journal:  Cancer Res       Date:  2015-11-10       Impact factor: 12.701

5.  Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases.

Authors:  Zoltan Lohinai; Zsolt Megyesfalvi; Kenichi Suda; Tunde Harko; Shengxiang Ren; Judit Moldvay; Viktoria Laszlo; Christopher Rivard; Balazs Dome; Fred R Hirsch
Journal:  Transl Lung Cancer Res       Date:  2019-12

Review 6.  Translational implications of tumor heterogeneity.

Authors:  Mariam Jamal-Hanjani; Sergio A Quezada; James Larkin; Charles Swanton
Journal:  Clin Cancer Res       Date:  2015-03-15       Impact factor: 12.531

Review 7.  Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.

Authors:  Maximilian Boesch; Sieghart Sopper; Alain G Zeimet; Daniel Reimer; Guenther Gastl; Burkhard Ludewig; Dominik Wolf
Journal:  Biochim Biophys Acta       Date:  2016-10-15

8.  TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients.

Authors:  Ritu Pandey; Nathan Johnson; Laurence Cooke; Benny Johnson; Yuliang Chen; Manjari Pandey; Jason Chandler; Daruka Mahadevan
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

9.  A novel cohort of cancer-testis biomarker genes revealed through meta-analysis of clinical data sets.

Authors:  Stephen J Sammut; Julia Feichtinger; Nicholas Stuart; Jane A Wakeman; Lee Larcombe; Ramsay J McFarlane
Journal:  Oncoscience       Date:  2014-05-06

10.  Reference-free inference of tumor phylogenies from single-cell sequencing data.

Authors:  Ayshwarya Subramanian; Russell Schwartz
Journal:  BMC Genomics       Date:  2015-11-10       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.